Veenat 100 Mg
- Manufacturer : Natco Pharma Ltd
- Equivalent Brands : Gleevec
- Generic Brands : Imatinib
Veenat (Imatinib Mesylate capsule) are used for the treatment of adult and paediatric patients with Ph+ CML (Philadelphia chromosome-positive chronic myeloid leukaemia) as well as to treat patients with Kit (CD117) positive unresectable and/or metastatic malignant GIST (gastrointestinal stromal tumours).
Veenat capsule (Generic) are manufactured by Natco Pharma Limited in the strengths of 100 mg and 400 mg.
Imatinib (Veenat) is a tyrosine kinase inhibitor. Tyrosine kinases are important proteins in the body that regulate how cells grow and divide. Imatinib cancer medication blocks the activity of this enzyme, which delivers a signal that causes cells to multiply. By blocking this enzyme, Veenat can help stop the spread of cancer cells.
Veenat containing the active ingredient imatinib is considered a protein tyrosine kinase inhibitor type of anticancer medication. The medication works by interfering with the action of abnormal protein that signals cancer cells to multiply. It can be used to treat certain types of leukemia, certain types of skin cancer, gastrointestinal stromal tumors (GIST) and bone marrow disorders.
Veenat is usually taken orally 1 to 2 times per day or as directed by a doctor. The capsules should always be taken with a meal along with a large glass of water. Contact a doctor for the correct dosage and length of treatment as it will depend on the patients condition and their response to the therapy. Avoid consuming grapefruits or grapefruit juice while using the medication as they can increase the risk of side effects. The capsules should be swallowed whole and not broken, chewed or crushed prior to consumption.
The warnings and precautions associated with Imatinib (Generic) therapy are as follows:
The prescribed dose of Imatinib capsule (Veenat) should be administered orally, along with a meal and a large glass of water. Doses of 400 mg or 600 mg should be administered once daily, whereas a dose of 800 mg should be administered as 400 mg twice a day. Imatinib capsule must not be crushed.
In case of Imatinib overdose the patient should be placed under observation and appropriate supportive treatment should be given. Nausea, vomiting, diarrhea, rash erythema, edema, swelling, fatigue, muscle spasms, thrombocytopenia, pancytopenia, abdominal pain, headache and decreased appetite were observed in case of overdose with 1,200 mg to 1,600 mg a day for a duration varying between 1 day to 10 days with adult patients. One patient experienced nausea, vomiting, abdominal pain, pyrexia, facial swelling, neutrophil count decreased, increase transaminases with a single dose of 6,400 mg.
Generic Imatinib capsule (Veenat by Natco) is used to treat certain types of leukemia in adult and pediatric patients. Generic Imatinib is also used to treat gastrointestinal stromal tumours(GIST), a type of tumor most often found in the wall of the stomach. This medicine is also used to treat Dermatofibrosarcoma Protuberans (DFSP) a rare type of cancer that occurs in the deep layers of skin in adult patients.
Veenat 100 mg Capsule is used to treat and prevent the growth of certain types of cancers of the blood cells, stomach, intestine, bone marrow, and skin.
Store Veenat capsule (Generic Gleevec) at controlled room temperature (59°F to 86°F, 15°C to 30°C). Protect from light. Protect from moisture.